GRAIL Quarterly Income Statement
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GRAIL revenue and earnings
In the quarter ended Jun 30, 2026, GRAIL generated $44.7 million in revenue, up 25.7% from the same quarter a year earlier. GRAIL reported a net loss of $110.2 million, compared with a loss of $114.0 million a year earlier. Operating margin was -388.9%.
Diluted earnings per share came in at -$2.56.
Summary generated from market data by MetaCap's automated system. Methodology
GRAIL income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.69M | 40.78M | 43.60M | 36.19M | 35.54M | 31.84M | 38.25M | 28.65M | 31.97M | 26.72M | 30.33M | 20.72M |
| Revenue growth (YoY) | +25.72% | +28.11% | +13.97% | +26.32% | +11.18% | +19.15% | +26.14% | +38.27% | — | +19.22% | — | — |
| Research & Development | 47.43M | 48.02M | 46.90M | 48.65M | 46.63M | 53.63M | 48.33M | 78.23M | 94.20M | 101.63M | — | — |
| Selling, General & Admin | 88.36M | 73.44M | 66.38M | 62.91M | 66.45M | 80.05M | 72.64M | 83.04M | 108.25M | 103.89M | — | — |
| Operating Income | -173.78M | -135.76M | -124.41M | -125.29M | -158.85M | -153.61M | -136.94M | -183.51M | -1.64B | -227.42M | -194.59M | -912.39M |
| Other Income (Expense) | 7.08M | 8.24M | 7.89M | 6.57M | 6.00M | 7.20M | 9.94M | 11.10M | 2.81M | 2.94M | 1.56M | 2.33M |
| Pretax Income | -166.71M | -127.52M | -116.52M | -118.72M | -152.86M | -146.41M | -126.99M | -172.41M | -1.64B | -224.48M | -193.03M | -910.06M |
| Income Tax | -56.46M | -34.34M | -17.34M | -29.74M | -38.87M | -40.20M | -29.93M | -46.72M | -53.14M | -5.57M | -5.50M | -18.61M |
| Net Income | -110.25M | -93.19M | -99.18M | -88.98M | -113.98M | -106.21M | -97.07M | -125.69M | -1.59B | -218.91M | -187.53M | -891.45M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -2.56 | -2.29 | -2.37 | -2.46 | -3.18 | -3.10 | -1.49 | -3.94 | -51.06 | -7.05 | — | -28.71 |
| EPS (Diluted) | -2.56 | -2.29 | -2.37 | -2.46 | -3.18 | -3.10 | -1.49 | -3.94 | -51.06 | -7.05 | — | -28.71 |
| Shares Outstanding (Basic) | 43.11M | 40.64M | — | 36.12M | 35.79M | 34.31M | — | 31.88M | 31.05M | 31.05M | — | 31.05M |
| Shares Outstanding (Diluted) | 43.11M | 40.64M | — | 36.12M | 35.79M | 34.31M | — | 31.88M | 31.05M | 31.05M | — | 31.05M |
| EBITDA | -169.68M | -131.56M | -120.09M | -120.89M | -154.26M | -148.91M | -132.08M | -178.86M | -1.64B | -222.01M | -189.25M | -907.17M |
| Operating Margin | -388.89% | -332.88% | -285.37% | -346.17% | -446.92% | -482.48% | -357.99% | -640.47% | -5133.85% | -851.10% | -641.67% | -4403.01% |
| Net Margin | -246.71% | -228.48% | -227.48% | -245.83% | -320.69% | -333.61% | -253.75% | -438.67% | -4958.83% | -819.26% | -618.37% | -4301.94% |
This table shows 12 quarterly periods of GRAIL's income statement, from Q2 2026 back to Q3 2023, across 15 line items including revenue, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow GRAL's reporting calendar. What is a income statement?